Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (CSE:BIOV)

Unique Value-Added Antiviral Vaccine Technology Platform

Dave Jackson September 15, 2021

Bullboard Posts (CSE:BIOV)

let's remember this date MAY 13 is the CTO extension date

EOM GLTA. 
Humanist - 1 day ago

RE:RE:New Press Release - BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY

triple amazing thank you BIOV...KEEP WORKING!!! it's a cash cow in the making once we suck and blow through all the red tape...
moneywagon - 10 days ago

RE:New Press Release - BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY

amazing thank you biov
Humanist - 10 days ago

RE:New Press Release - BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Thank you biov foranswering my question.. another quick one, is it for sure end of april? you usedthe word anticipate, it doesn't...
Humanist - April 5, 2024

where are the financials? they said end of march!

why no mention about it and still not released? 
Humanist - April 3, 2024

CEASE TRADE ORDER...OUCH

I tried to warn ppl, this business requires a ton of cash. Adios BIOV!
Magnum2 - March 8, 2024